Oct 21 (Reuters) - Eurofins Scientific SE EUFI.PA:
4.0% ORGANIC REVENUE GROWTH IN 9M 2025; EUROFINS ON TRACK FOR SOLID FULL YEAR GROWTH AND MARGIN EXPANSION
Q3 REVENUES AT EUR 1.80 BILLION
CONFIRMS ITS OBJECTIVES FOR FY 2025 AND FY 2027 AS ANNOUNCED AT FY 2024 RESULTS PRESENTATION
EXPECTS -1.6% REVENUE GROWTH HEADWIND FROM USD
WITH COMPLETION OF SHARE BUYBACK, TOPICS OF INTEREST TO EUROFINS' KEY STAKEHOLDERS IN RECENT QUARTERS HAVE NOW BEEN FULLY ADDRESSED
DUE TO FOREIGN EXCHANGE, IF US DOLLAR/EURO RATE AS OF END OF Q3 HAD HELD FOR WHOLE OF FY 2025, THEN THAT WOULD RESULT IN REPORTED REVENUE FOR FY 2025 BEING AROUND 3% LOWER THAN AT 2024 AVERAGE RATES, AND EBITDA MARGIN AROUND 20BPS LOWER
Source text: ID:nBw8B6vS8a
Further company coverage: EUFI.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))